Positron Corporation (POSC)

[roelien]

Positron Subsidiary Files Patent Applications for Proprietary Radiation Detection Technologies To Be Used in PET Scanners and Homeland Security Devices
Friday March 2, 4:01 pm ET 2008
HOUSTON--(BUSINESS WIRE)--Positron Corporation (OTCBB: POSC - News; the Company), a developer and manufacturer of Positron Emission Tomography (PET) medical devices, announced today that through its subsidiary developed intellectual property in the field of solid state photo detection and its applications. The Company has four patents pending covering the design and construction of medical diagnostic molecular imaging scanners and radiation detection scanners for homeland security with its new class of solid state photodetectors. The compact, low-cost photodetectors have increased sensitivity that can detect a single quantum of light and may significantly reduce the cost of future PET scanners while improving spatial resolution and portability. Solid state photodetectors are the key component in the development of compact organ-specific PET scanners and effective radiation detection devices for monitoring of radiation proliferation by parties unfriendly to national security interests. The Company's research and development projects were conducted at facilities across North America with the participation of a team of collaborating scientists directed by Dr. Irving Weinberg. Dr. Weinberg is Chief Scientific Officer of the Positron research and development subsidiary.
The miniaturization afforded with this solid state photodetector technology is designed as the evolution of positron emission technologies that will enable the development of the next generation of efficient and economical full-body scanning devices, integrated PET/MRI scanners and the development of a single-use organ specific low-cost camera that can be disposed of after a single medical procedure.
The homeland security application is based on the ability to build a small transportable device using the compact solid state technology to detect very low levels of radiation emitted by illicit radioactive materials from a distance.
Dr. Irving Weinberg stated: "The solid state photodetectors will allow us to build radiation detection systems with high sensitivity. In new medical diagnostic nuclear imaging systems it will allow reduced patient radiation exposure because of lower radiopharmaceutical dosage, while in the homeland security application, a small radiation event can be detected from a substantial distance".
About Positron:
Positron Corporation designs, manufactures, markets and supports advanced medical imaging devices utilizing positron emission tomography (PET) technology. Positron Corporation incorporates patented and proprietary software and hardware technology for the diagnosis and treatment of patients in the areas of cardiology, oncology and neurology. Positron Corporation offers unique combination of low cost technology and disease specific software solutions differentiating themselves from all other medical device manufacturers. Positron's PET systems are in use at leading medical facilities throughout North America and in select International markets. Additional information may be found at www.positron.com.
Positron Corporation ("Positron" "POSC") is the first name in positron emission tomography (PET). Positron designs, markets, services and develops software solutions for their advanced medical imaging devices utilizing PET technology. Positron has the most advanced technology for Cardiology PET imaging and is well positioned to take advantage of its existing cardiac brand with innovative, cost-effective medical devices in conjunction with a complete disease management software solution.
PET differs from other imaging technologies by measuring biological processes of organs and tissues and produces functional images for the diagnosis and treatment of patients in the areas of cardiology, oncology and neurology. Positron offers a unique combination of low cost technology and disease specific software solutions differentiating themselves from all other medical device manufacturers. Positron has an experienced clinical management team with more than a decade of clinical expertise in many disciplines within the Cardiac PET industry.
In 2005 Positron formed a joint venture with Neusoft Medical Systems in Shenyang, China called Neusoft-Positron Medical Systems Co., Ltd (NPMS). NPMS will manufacture all of Positron’s PET and PET/CT systems, dramatically lowering manufacturing costs and allowing Positron to be much more competitive in the global marketplace. This efficiency enables Positron to market and deliver the lowest priced, high quality PET and PET/CT devices in the industry.
In 2006/2007 Positron acquired Imaging PET Technologies (IPT), parent corporation of IS2 Medical Systems. IS2 Medical Systems develops builds and services Nuclear Medicine Gamma Cameras (SPECT) offering clinical users the highest resolution in the industry, the most robust feature set and the highest levels of performance and reliability, all at the best prices. A scintillation, or gamma camera, is a diagnostic medical imaging system that is part of a family of systems commonly referred to as .body scanners. Gamma cameras are used in the diagnosis of heart disease, cancers and a variety of other disorders. A mechanical frame (a gantry) rotates an electronic detector head around a patient in order to take a series of clinical images of inside of the body. The scientific team responsible for the design and continued innovation of the company’s world-class cameras comprise more than 125 years of expertise in nuclear medicine physics, mathematics and engineering. The Company is ISO certified and meets related medical device, safety and regulatory requirements, including USA FDA and Health Canada approval, and has a CE Mark necessary for European distribution.
IPT's R&D subsidiary, Quantum Molecular Technologies (QMT) aims to become a significant player by revolutionizing molecular imaging. QMT’s current research is focused on the design and manufacturing of new solid state detectors and data acquisition electronics. This solid state detector will have direct impact on all current imagining modalities as well as new markets including homeland security and high energy physics technologies.
With the acquisition of IPT and its joint venture with Neusoft Medical, Positron is able to offer SPECT, SPECT/CT, PET and PET/CT products in the molecular imaging field and positioned to be at the cutting-edge of the next frontier in molecular imaging. Positron’s plan of action is to take advantage of integration and synergies between companies to increase sales and marketing, product service, clinical applications and R&D.
As part of its full solution, Positron is developing disease-specific software for end users. Positron’s software will be ready to market with the release of its PET camera for NPMS. During 2007 Positron intends to debut its new scanner technology and software solutions package at the 54th annual meeting of the Society of Nuclear Medicine in Washington D.C. and to the Nuclear Cardiology community at the 12th annual meeting of the American Society of Nuclear Cardiology in San Diego, California
Patent filing: http://www.freshpatents.com/-dt20090430ptan20090108217.php?type=description
Founders of the Altruis PET Scanner
Dr. Irvine Weinberg…Is the Chief R&D of Positron Corp…Owns it’s own company called, Naviscan PET Systems, Inc.
11180 Roselle St.
San Diego, CA, 92121, USA.

Dr Irvin Weinberg is renowned for the development of PEM (PET Mammography) technology for detecting breast cancer.
The IMAGIN diagnostics Centers (IMGM) has listed as it's affiliates:

http://www.imagincentres.com/Affiliates.html

Naviscan Pet Systems
Positron
Quantum Molecular Technologies
IS2/IPT

Naviscan PET systems is Dr Irvin Weinberg's company (he is the founder and inventor of the PEM (only Positron Emission Mammography on the market)......This is a private company and boast installed PEM's

http://www.naviscan.com/

They (the management team of IMGM anD POsc) may not have the best track record in the business but they sure seem to have a very good market cornered here..... Dr Irvine Weinber affiliation is definitely giving them a big boost as far as creditability....